DGRS WisdomTree US Smallcap Quality Dividend Growth Fund
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| AROC | 2.77% |
| CRC | 2.29% |
| CALM | 2.06% |
| AVT | 1.82% |
| MGY | 1.78% |
| NOG | 1.74% |
| VCTR | 1.72% |
| BKE | 1.69% |
| LCII | 1.57% |
| CNS | 1.54% |
ETF Analysis
Fund Overview
WisdomTree US Smallcap Quality Dividend Growth Fund (DGRS) currently reports 199 stock positions (subject to change), placing it in the broadly diversified range by holdings breadth. The top line-up is AROC (2.77%), CRC (2.29%), CALM (2.06%), with AROC as the largest single weight at 2.77%. Together, the top three holdings account for 7.12%, which indicates that performance drivers are distributed more evenly across the broader basket. This architecture allows the fund to express a clear investment thesis at the top while relying on the broader basket to manage idiosyncratic volatility.
Profitability & Capital Efficiency
From a capital efficiency perspective, ROIC is 14.99%, WACC is 7.98%, and the economic spread is 7.01%. On balance, holdings marginally exceed their cost of capital, suggesting modest but present value creation. Supporting metrics show ROE at 17.79% and ROA at 7.29%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that is value-creative but with less room for execution slippage.
Valuation
Turning to how the market is pricing the underlying earnings, trailing P/E of 15.80, forward P/E of 11.86, PEG of 1.68. Trailing and forward valuations are closely aligned, pointing to a market that is pricing continuity rather than improvement in the earnings outlook. A PEG in this range suggests valuation is fair rather than compelling — the portfolio is priced adequately for its growth, with limited buffer for downside revisions. At 2.32, the aggregate current ratio indicates adequate but not exceptional balance sheet coverage. The combined picture across P/E, forward P/E, PEG, and current ratio suggests a portfolio that is priced for continued execution — where disappointment would be costly and outperformance would likely require positive earnings surprises.
Margins & Cash Generation
On the margin front: gross margin sits at 41.03%, operating margin at 20.95%, and free cash flow margin at 16.45%. At this level, the portfolio reflects reasonable cost discipline and adequate pricing leverage at the production layer. Operating margins sit in a healthy range — not exceptional, but indicating reasonable operational efficiency. Strong free cash flow margins point to businesses with meaningful financial flexibility and limited dependence on external capital. The margin stack is not uniformly strong, which means the portfolio's earnings resilience under adverse conditions is less certain.
Growth & Forward Outlook
On the forward picture: TTM revenue growth of 13.55% reflecting consistent if unspectacular revenue expansion. Consensus EPS estimates point to 33.2% earnings growth over the next 12 months — a compelling near-term earnings catalyst that, if delivered, changes the valuation conversation materially. Analyst price targets suggest street expectations imply a constructive but measured return profile on a 12-month view. Revenue growth is grounded in reported results; price targets are forward projections that embed assumptions about multiple expansion, earnings delivery, and macro conditions. The key risk in both directions is whether the underlying businesses can maintain their operating trajectory as macro and sector conditions evolve. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
BuyThe composite picture leans positive, with capital efficiency and growth momentum providing the core of the investment thesis.
This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.